Xtant Medical Holdings (XTNT) Amortization of Deferred Charges (2012 - 2023)

Xtant Medical Holdings (XTNT) has 6 years of Amortization of Deferred Charges data on file, last reported at $2000.0 in Q1 2023.

• On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $2000.0 in Q1 2023; TTM through Mar 2023 was $8000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $4000.0, down 55.56% from the prior year.
• Amortization of Deferred Charges for Q1 2023 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for XTNT reached as high as $4000.0 in Q4 2020 and fell as low as $1000.0 in Q4 2021.
• Historically, Amortization of Deferred Charges has averaged $2500.0 across 4 years, with a median of $2500.0 in 2021.
• Across the five-year window, Amortization of Deferred Charges slumped 75.0% in 2021 and surged 100.0% in 2022, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $4000.0 in 2020, then slumped by 75.0% to $1000.0 in 2021, then jumped by 100.0% to $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $2000.0 in Q1 2023, $2000.0 in Q4 2022, and $3000.0 in Q3 2022.